Fiera Capital Corp boosted its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 42.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 511,368 shares of the company’s stock after acquiring an additional 153,393 shares during the quarter. Fiera Capital Corp owned about […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Sells $432,227.20 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $140.00 at Citigroup themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 3,040 shares of Neurocrine Biosciences stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $142.18, for a total value of $432,227.20. Following the transaction, the chief executive officer now directly owns 504,919 shares of […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.31, Briefing.com reports. Neurocrine Biosciences had a return on equity of 12.85% and a net margin of 13.23%. The business had revenue of […]